103 related articles for article (PubMed ID: 16322282)
1. Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients.
Nagato T; Kobayashi H; Kishibe K; Takahara M; Ogino T; Ishii H; Oikawa K; Aoki N; Sato K; Kimura S; Shimizu N; Tateno M; Harabuchi Y
Clin Cancer Res; 2005 Dec; 11(23):8250-7. PubMed ID: 16322282
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomas.
Ramakrishnan R; Donahue H; Garcia D; Tan J; Shimizu N; Rice AP; Ling PD
PLoS One; 2011; 6(11):e27271. PubMed ID: 22102884
[TBL] [Abstract][Full Text] [Related]
3. p53 Mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease.
Quintanilla-Martinez L; Kremer M; Keller G; Nathrath M; Gamboa-Dominguez A; Meneses A; Luna-Contreras L; Cabras A; Hoefler H; Mohar A; Fend F
Am J Pathol; 2001 Dec; 159(6):2095-105. PubMed ID: 11733360
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 reverses Adriamycin resistance in nasal NK/T-cell lymphoma via downregulation of ABCC4 and inactivation of the JAK2/STAT3/NF-κB/P65 pathway.
Gao M; Liu L; Zhang X; Li Z; Zhang M
Environ Toxicol Pharmacol; 2021 Jul; 85():103639. PubMed ID: 33771682
[TBL] [Abstract][Full Text] [Related]
5. Sufficiently activated mature natural killer cells derived from peripheral blood mononuclear cells substantially enhance antitumor activity.
Liu C; Li Y; Li Y; Hu M; Wang H; Lu S; Li Z; Dilimulati D; Jiao S; Lu S; Zhao W
Immun Inflamm Dis; 2024 Jan; 12(1):e1143. PubMed ID: 38270321
[TBL] [Abstract][Full Text] [Related]
6. Expression of CXCL8 (IL-8) in the Pathogenesis of T-Cell Acute Lymphoblastic Leukemia Patients.
Pandey S; Singh R; Habib N; Singh V; Kushwaha R; Tripathi AK; Mahdi AA
Cureus; 2023 Sep; 15(9):e45929. PubMed ID: 37885528
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral Delivery of Interleukin 9 via Oncolytic Vaccinia Virus Elicits Potent Antitumor Effects in Tumor Models.
Ye J; Chen L; Waltermire J; Zhao J; Ren J; Guo Z; Bartlett DL; Liu Z
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473379
[TBL] [Abstract][Full Text] [Related]
8. Soluble CD27 as a predictive biomarker for intra-tumoral CD70/CD27 interaction in nasopharyngeal carcinoma.
Nagato T; Komatsuda H; Hayashi R; Takahara M; Ujiie N; Kosaka A; Ohkuri T; Oikawa K; Sato R; Wakisaka R; Kono M; Yamaki H; Ohara K; Kumai T; Kishibe K; Katada A; Hayashi T; Kobayashi H
Cancer Sci; 2024 Apr; 115(4):1073-1084. PubMed ID: 38279834
[TBL] [Abstract][Full Text] [Related]
9.
Zhang X; Huang W; Qiu Y; Chen Z; Song L; Yang Q; Kang L
Am J Nucl Med Mol Imaging; 2023; 13(6):245-258. PubMed ID: 38204603
[TBL] [Abstract][Full Text] [Related]
10. The Dichotomy of Interleukin-9 Function in the Tumor Microenvironment.
Cannon A; Pajulas A; Kaplan MH; Zhang J
J Interferon Cytokine Res; 2023 Jun; 43(6):229-245. PubMed ID: 37319357
[TBL] [Abstract][Full Text] [Related]
11. Role and Potential of Different T Helper Cell Subsets in Adoptive Cell Therapy.
Andreu-Sanz D; Kobold S
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980536
[TBL] [Abstract][Full Text] [Related]
12. Expression of soluble CD27 in extranodal natural killer/T-cell lymphoma, nasal type: potential as a biomarker for diagnosis and CD27/CD70-targeted therapy.
Nagato T; Komatsuda H; Hayashi R; Takahara M; Kishibe K; Yasuda S; Yajima Y; Kosaka A; Ohkuri T; Oikawa K; Harabuchi S; Kono M; Yamaki H; Wakisaka R; Hirata-Nozaki Y; Ohara K; Kumai T; Katada A; Hayashi T; Harabuchi Y; Kobayashi H
Cancer Immunol Immunother; 2023 Jul; 72(7):2087-2098. PubMed ID: 36811663
[TBL] [Abstract][Full Text] [Related]
13. Amphiregulin/epidermal growth factor receptor/hypoxia-inducible factor-1α pathway regulates T helper 9 and T cytotoxic 9 cell response in adult patients with infectious mononucleosis.
Li Y; Li L; Zhang W; Gao Y
Biomol Biomed; 2023 Feb; 23(1):63-72. PubMed ID: 36154925
[TBL] [Abstract][Full Text] [Related]
14. Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers.
Peña-Romero AC; Orenes-Piñero E
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406451
[TBL] [Abstract][Full Text] [Related]
15. Increased serum level of interleukin-6 correlates with negative prognostic factors in extranodal NK/T-cell lymphoma.
Bao C; Zhou D; Zhu L; Qian W; Ye X
Transl Cancer Res; 2020 Apr; 9(4):2378-2389. PubMed ID: 35117598
[TBL] [Abstract][Full Text] [Related]
16. Interleukin (IL)-9 Supports the Tumor-Promoting Environment of Chronic Lymphocytic Leukemia.
Patrussi L; Capitani N; Baldari CT
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944921
[TBL] [Abstract][Full Text] [Related]
17. Extranodal NK/T-Cell Lymphoma, Nasal Type: Genetic, Biologic, and Clinical Aspects with a Central Focus on Epstein-Barr Virus Relation.
Takahara M; Kumai T; Kishibe K; Nagato T; Harabuchi Y
Microorganisms; 2021 Jun; 9(7):. PubMed ID: 34202088
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk between the Producers and Immune Targets of IL-9.
Do-Thi VA; Lee JO; Lee H; Kim YS
Immune Netw; 2020 Dec; 20(6):e45. PubMed ID: 33425430
[TBL] [Abstract][Full Text] [Related]
19. IL-9-producing T cells: potential players in allergy and cancer.
Angkasekwinai P; Dong C
Nat Rev Immunol; 2021 Jan; 21(1):37-48. PubMed ID: 32788707
[TBL] [Abstract][Full Text] [Related]
20. Th9 Cell Differentiation and Its Dual Effects in Tumor Development.
Chen T; Guo J; Cai Z; Li B; Sun L; Shen Y; Wang S; Wang Z; Wang Z; Wang Y; Zhou H; Cai Z; Ye Z
Front Immunol; 2020; 11():1026. PubMed ID: 32508847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
